May 20, 2008
Veeda Oncology (Columbus, Ohio) has acquired French cancer trials specialist Biologie et Industrie for an undisclosed sum.
May 15, 2008
Quintiles Transnational (Research Triangle Park, North Carolina) has signed an agreement to acquire Eidetics (Boston, Massachusetts), a privately held healthcare market research and consulting firm. Financial terms were not disclosed.
Apr 23, 2008
Pharmaceutical services company i3 (Basking Ridge, New Jersey) has acquired Russian CRO Lege Artis (Moscow). Financial terms were not disclosed.
Apr 14, 2008
Mixed results for Novartis’s first-in-class direct renin inhibitor, Rasilez (aliskiren), have been reported from the ALLAY study at the American College of Cardiology meeting in Chicago, US.
Apr 02, 2008
Parexel International (Boston, Massachusetts) has sold its stand-alone bioanalytical laboratory in Poitiers, France, to privately owned Indian CRO Synchron Research Services (Ahmedabad, Gujarat)
Mar 31, 2008
Quintiles Transnational (North Carolina) has signed an agreement with Medca Japan to provide central laboratory services in Japan. Quintiles will have its own staff at the Medca Japan laboratory in Saitama, a city in the Greater Tokyo area
Mar 03, 2008
QPS (Newark, Delaware) has acquired early-phase specialist Bio-Kinetic Clinical Applications (Springfield, Missouri). Bio-Kinetic has a 240-bed Phase I facility - one of the largest in the US owned by an independent CRO.
Feb 29, 2008
US biotechnology company GeoVax Labs’ (Atlanta, Georgia) HIV/AIDS vaccine is expected to enter Phase IIa human trials in mid-2008.
Feb 19, 2008
Clinical technology specialist ClinPhone (Nottingham, UK) has rejected a preliminary approach from Parexel International regarding a possible offer for the company.
Jan 29, 2008
Polish CRO KCR (Warsaw) has acquired its Czech counterpart DUX Consulting (Prague). The value of the transaction was not disclosed.